1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 18 MAY 2015

Cancer Drug News 18 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Manufacturing Process Will Have Significant Impact On CAR-T Therapy Price
Industry Trend Analysis - Medigene's Immunotherapy Approach To Attract Investment
Industry Brief - FDA Grants ODD To GlycoMimetics' GMI-1271 For AML
Industry Trend Analysis - Aurora Kinase Inhibitors Face Bleak Future
Industry Trend Analysis - Roche Set To Undertake Big Oncology Filings
Industry Brief - OSE Pharma/RAFA Sign Tedopi Distribution Deal In Israel
Industry Brief - Sacituzumab Govitecan Gains FDA Fast Track Designation For MNSCLC
Industry Brief - TRACON's TRC105 Gains FDA Fast Track Designation For Advanced RCC
Industry Brief - Algenpantucel-L Phase III PC Trial Continues Following Second Interim Analysis
Industry Brief - Merck Receives FDA Fast Track Designation For Evofosfamide In Advanced PC
Industry Brief - Positive Fruquintinib Results Trigger Milestone To HMP From Lilly
Industry Brief - First Patient Dosed In Tipifarnib Phase II Study In Advanced Cancers With HRAS Mutations
Industry Brief - Prima BioMed Enters Japanese Collaboration For IMP321
Industry Brief - NCC/Takeda Partner To Develop Anticancer Agents
Industry Brief - Lilly/BioNTech Enter Cancer Immunotherapies Research Collaboration
Industry Brief - Bavarian Nordic Secures EUR50mn Loan From EIB
Industry Brief - US Patent Protection For Immunomedics' Sacituzumab Govitecan Extended
Industry Brief - BeiGene Raises Funds For Development Of Oncology Candidates
Industry Brief - Mayne Invests In HPP To Accelerate SUBA-Itraconazole Development
Industry Brief - TGA Approves Akynzeo For CINV Prevention
Industry Brief - FDA Accepts Heron's HTX-019 Development Pathway
Industry Trend Analysis - Adding To Oncology Portfolio Will Secure Baxalta's Future Growth
Industry Brief - Ridgeback Invests AUD15mn In Prima BioMed

Table Of Contents

Cancer Drug News 18 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the Netherlands

  • December 2016
    18 pages
  • Therapy  

  • Netherlands  

    Canada  

View report >

Therapy Market and Blood Disease Statistics

  • December 2016
    8 pages
  • Therapy  

    Blood Disease  

View report >

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.